Comprehensive assessments of immuno‐oncology drug‐based combination therapies as first‐line treatment for advanced renal cell carcinoma

K Harada, H Miyake, J Furukawa… - … Journal of Urology, 2022 - Wiley Online Library
Over the last decade, there have been substantial progress in the field of systemic therapy
for advanced renal cell carcinoma. Through the transition from treatment with cytokines to …
被引用次数：3 相关文章

Comprehensive assessments of immuno‐oncology drug‐based combination therapies as first‐line treatment for advanced renal cell carcinoma.

K Harada, H Miyake, J Furukawa… - … Journal of Urology, 2022 - search.ebscohost.com
Over the last decade, there have been substantial progress in the field of systemic therapy
for advanced renal cell carcinoma. Through the transition from treatment with cytokines to …

Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma.

KI Harada, H Miyake, J Furukawa… - … Journal of Urology …, 2022 - europepmc.org
Over the last decade, there have been substantial progress in the field of systemic therapy
for advanced renal cell carcinoma. Through the transition from treatment with cytokines to …

Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma

KI Harada, H Miyake, J Furukawa… - … journal of urology …, 2022 - pubmed.ncbi.nlm.nih.gov
Over the last decade, there have been substantial progress in the field of systemic therapy
for advanced renal cell carcinoma. Through the transition from treatment with cytokines to …